Form 8-K - Current report:
SEC Accession No. 0000950170-25-104151
Filing Date
2025-08-06
Accepted
2025-08-06 16:35:10
Documents
12
Period of Report
2025-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bioa-20250806.htm   iXBRL 8-K 51280
2 EX-99.1 bioa-ex99_1.htm EX-99.1 214338
3 GRAPHIC img161644396_0.jpg GRAPHIC 75817
  Complete submission text file 0000950170-25-104151.txt   492609

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20250806.xsd EX-101.SCH 25813
14 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20250806_htm.xml XML 4883
Mailing Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42279 | Film No.: 251190198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)